发明名称 |
Engineered Dendritic Cells and Uses for the Treatment of Cancer |
摘要 |
This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL-12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human. |
申请公布号 |
US2013149290(A1) |
申请公布日期 |
2013.06.13 |
申请号 |
US201313737316 |
申请日期 |
2013.01.09 |
申请人 |
INTREXON CORPORATION;SYSTEM OF HIGHER EDUCATION UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH;UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION;INTREXON CORPORATION |
发明人 |
BRAUGHLER J. MARK;KUMAR PRASANNA;STORKUS WALTER J.;OKADA HIDEHO |
分类号 |
A61K35/14;C12N5/0784 |
主分类号 |
A61K35/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|